FDA spends $1.2M on VR-enabled hub to spur development of at-home care devices
The Food and Drug Administration’s (FDA’s) device center launched an initiative to promote at-home medical device development with a focus on health equity in at-home care. | Medical devices and other innovations that make acute and on-going at-home clinical management possible are receiving a boost in attention from the FDA. The agency will use virtual reality to simulate patients’ home environments for developers and policymakers.